---
figid: PMC9366312__gr5
figtitle: Overcoming Mycobacterium tuberculosis through small molecule inhibitors
  to break down cell wall synthesis
organisms:
- Mycobacterium tuberculosis
- Homo sapiens
organisms_ner:
- Escherichia coli str. K-12 substr. MG1655
pmcid: PMC9366312
filename: gr5.jpg
figlink: /pmc/articles/PMC9366312/figure/fig5/
number: F5
caption: UDP-GlcNAc biosynthetic pathway.
papertitle: Overcoming Mycobacterium tuberculosis through small molecule inhibitors
  to break down cell wall synthesis.
reftext: Wenbin Kuang, et al. Acta Pharm Sin B. 2022 Aug;12(8):3201-3214.
year: '2022'
doi: 10.1016/j.apsb.2022.04.014
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: Mycobacterium tuberculosis | Small molecule inhibitor | Cell wall synthesis
  | Antibiotic resistance
automl_pathway: 0.9313865
figid_alias: PMC9366312__F5
figtype: Figure
redirect_from: /figures/PMC9366312__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9366312__gr5.html
  '@type': Dataset
  description: UDP-GlcNAc biosynthetic pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - glk
  - pgi
  - glmS
  - glmM
  - glmU
---
